WallStreetZenWallStreetZen

NASDAQ: CBAT
Cbak Energy Technology Inc Stock

$0.88-0.02 (-2.22%)
Updated Mar 31, 2023
CBAT Price
$0.88
Fair Value Price
$0.95
Market Cap
$78.31M
52 Week Low
$0.80
52 Week High
$1.70
P/E
8x
P/B
0.65x
P/S
0.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$222.07M
Earnings
$10.41M
Gross Margin
6.9%
Operating Margin
0.93%
Profit Margin
4.7%
Debt to Equity
1.02
Operating Cash Flow
$20M
Beta
0.95
Next Earnings
Apr 12, 2023
Ex-Dividend
N/A
Next Dividend
N/A

CBAT Overview

CBAK Energy Technology, Inc., together with its subsidiaries, develops, manufactures, and sells lithium batteries in Mainland China, the United States, Korea, Europe, and internationally. Its products are used in various applications, including electric vehicles, such as electric cars, electric buses, and hybrid electric cars and buses; light electric vehicles that include electric bicycles, electric motors, and sight-seeing cars; and electric tools, energy storage, uninterruptible power supply, and other high power applications, as well as cordless power tools. The company was formerly known as China BAK Battery, Inc. and changed its name to CBAK Energy Technology, Inc. in January 2017. CBAK Energy Technology, Inc. was incorporated in 1999 and is based in Dalian, China.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CBAT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CBAT ($0.88) is undervalued by 6.92% relative to our estimate of its Fair Value price of $0.95 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CBAT ($0.88) is not significantly undervalued (6.92%) relative to our estimate of its Fair Value price of $0.95 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CBAT was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CBAT due diligence checks available for Premium users.

Be the first to know about important CBAT news, forecast changes, insider trades & much more!

CBAT News

Valuation

CBAT fair value

Fair Value of CBAT stock based on Discounted Cash Flow (DCF)
Price
$0.88
Fair Value
$0.95
Undervalued by
6.92%
CBAT ($0.88) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CBAT ($0.88) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CBAT was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CBAT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
8x
Industry
19.51x
Market
22.13x
CBAT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CBAT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CBAT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.65x
Industry
3.53x
CBAT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CBAT's financial health

Profit margin

Revenue
$57.7M
Net Income
-$290.0
Profit Margin
0%
CBAT's Earnings (EBIT) of $2.07M... subscribe to Premium to read more.
Interest Coverage Financials
CBAT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$251.2M
Liabilities
$123.6M
Debt to equity
1.02
CBAT's short-term assets ($129.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBAT's short-term assets ($129.24M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBAT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CBAT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$643.8k
Investing
-$3.6M
Financing
$7.5M
CBAT's operating cash flow ($19.66M)... subscribe to Premium to read more.
Debt Coverage Financials

CBAT vs Electrical Equipment & Part Stocks

TickerMarket Cap1d %P/EP/B
CBAT$78.31M-2.22%8.00x0.65x
FLUX$77.90M+1.25%-7.84x7.48x
NEOV$84.85M-2.10%N/A11.78x
ELBM$66.97M+3.54%N/A0.60x
BURU$89.67M-28.23%-1.63x-48.68x

Cbak Energy Technology Stock FAQ

What is Cbak Energy Technology's quote symbol?

NASDAQ: CBAT) Cbak Energy Technology trades on the NASDAQ under the ticker symbol CBAT. Cbak Energy Technology stock quotes can also be displayed as NASDAQ: CBAT.

If you're new to stock investing, here's how to buy Cbak Energy Technology stock.

What is the 52 week high and low for Cbak Energy Technology (NASDAQ: CBAT)?

(NASDAQ: CBAT) Cbak Energy Technology's 52-week high was $1.70, and its 52-week low was $0.80. It is currently -48.24% from its 52-week high and 10% from its 52-week low.

How much is Cbak Energy Technology stock worth today?

(NASDAQ: CBAT) Cbak Energy Technology currently has 88,990,858 outstanding shares. With Cbak Energy Technology stock trading at $0.88 per share, the total value of Cbak Energy Technology stock (market capitalization) is $78.31M.

Cbak Energy Technology stock was originally listed at a price of $26.50 in Feb 14, 2005. If you had invested in Cbak Energy Technology stock at $26.50, your return over the last 18 years would have been -96.68%, for an annualized return of -17.24% (not including any dividends or dividend reinvestments).

How much is Cbak Energy Technology's stock price per share?

(NASDAQ: CBAT) Cbak Energy Technology stock price per share is $0.88 today (as of Mar 31, 2023).

What is Cbak Energy Technology's Market Cap?

(NASDAQ: CBAT) Cbak Energy Technology's market cap is $78.31M, as of Apr 1, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cbak Energy Technology's market cap is calculated by multiplying CBAT's current stock price of $0.88 by CBAT's total outstanding shares of 88,990,858.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.